Antibody-Mediated Control of Anellovirus Infection: Evidence from People Who Inject Drugs
To characterize plasma anellovirus infection over time, we performed metagenomic sequencing on plasma collected every 6 months for two years from ten participants. Prior to sequencing, samples were enriched for circular DNA using rolling circle amplification.